Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Cancer Cytopathology
|
June 22, 2021
Validation of BRCA testing on cytologic samples of high-grade serous carcinoma
Si Kei Lou, Sylvie Grenier, Melanie Care, et al.
Molecular Oncology
|
October 8, 2020
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program
Melanie Care, Jeanna McCuaig, Blaise Clarke, et al.
The American Journal of Surgical Pathology
|
June 11, 2021
Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier
Nida S Safdar, Emily F Thompson, C Blake Gilks, et al.
Clinical and Translational Radiation Oncology
|
March 30, 2018
The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP)
Rachel Glicksman, Naz Chaudary, Melania Pintilie, et al.
Journal of Proteome Research
|
April 16, 2011
In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry
Sarah Elschenbroich, Vladimir Ignatchenko, Blaise Clarke, et al.
American Journal of Clinical Pathology
|
August 26, 2025
Selecting high-throughput scanners for clinical use: A multicenter institution experience
Joice Soliman, Karen Weiser, Iman Ahmed, et al.
Oncotarget
|
December 6, 2019
Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models
Tony Yeung, Oliver Fung, Mikhail Bashkurov, et al.
The American Journal of Pathology
|
February 20, 2018
A Genomically Characterized Collection of High-Grade Serous Ovarian Cancer Xenografts for Preclinical Testing
Paulina Cybulska, Jocelyn M Stewart, Azin Sayad, et al.
Gynecologic Oncology Reports
|
March 15, 2021
Can <i>TP53</i> variant negative be high-grade serous ovarian carcinoma? A case series
Lawrence Kasherman, Swati Garg, Nairi Tchrakian, et al.
Human Pathology
|
July 8, 2008
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
C Blake Gilks, Diana N Ionescu, Steve E Kalloger, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Cancer Cytopathology
|
June 22, 2021
Validation of BRCA testing on cytologic samples of high-grade serous carcinoma
Si Kei Lou, Sylvie Grenier, Melanie Care, et al.
Molecular Oncology
|
October 8, 2020
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program
Melanie Care, Jeanna McCuaig, Blaise Clarke, et al.
The American Journal of Surgical Pathology
|
June 11, 2021
Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier
Nida S Safdar, Emily F Thompson, C Blake Gilks, et al.
Clinical and Translational Radiation Oncology
|
March 30, 2018
The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP)
Rachel Glicksman, Naz Chaudary, Melania Pintilie, et al.
Journal of Proteome Research
|
April 16, 2011
In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry
Sarah Elschenbroich, Vladimir Ignatchenko, Blaise Clarke, et al.
American Journal of Clinical Pathology
|
August 26, 2025
Selecting high-throughput scanners for clinical use: A multicenter institution experience
Joice Soliman, Karen Weiser, Iman Ahmed, et al.
Oncotarget
|
December 6, 2019
Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models
Tony Yeung, Oliver Fung, Mikhail Bashkurov, et al.
The American Journal of Pathology
|
February 20, 2018
A Genomically Characterized Collection of High-Grade Serous Ovarian Cancer Xenografts for Preclinical Testing
Paulina Cybulska, Jocelyn M Stewart, Azin Sayad, et al.
Gynecologic Oncology Reports
|
March 15, 2021
Can <i>TP53</i> variant negative be high-grade serous ovarian carcinoma? A case series
Lawrence Kasherman, Swati Garg, Nairi Tchrakian, et al.
Human Pathology
|
July 8, 2008
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
C Blake Gilks, Diana N Ionescu, Steve E Kalloger, et al.
Page
of 7